COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,099 Articles (22,658 medRxiv, 8,441 bioRxiv)

Most recent first Previous |  Page 95: Articles 941-950  | Next

Digital health app data reveals an effect of ovarian hormones on long COVID and myalgic encephalomyelitis symptoms
Goodship, A., Preston, R., Hicks, J. T., Leeming, H., Morgenstern, C., Male, V.
10.1101/2025.01.24.25321092 — Posted: 2025-01-27
Seasonal variations and time trends of deaths from COVID-19 in Italy, September 2021 - September 2024: a segmented linear regression study
Roccetti, M., De Rosa, E. M.
10.1101/2025.01.25.25321115 — Posted: 2025-01-27
Assessment of SARS-CoV2 genome sequence recovery from four lateral flow device products available in the UK.
Lewandowski, K., Stokes, M., Alexandridou, A., Fenwick, A., White, M. L., Crook, J., Rogers-Broadway, K.-R., Ryan, C., Williamson, D., Vipond, R., Pullan, S. T.
10.1101/2025.01.23.25321032 — Posted: 2025-01-25
Accuracy of rapid antigen testing for COVID-19 in shelter settings
Garad, Y., Manea, A., Pak, N., Barker, B., Kasperavicius, D., Danok, L., Baral, S., Orkin, A. M., Siddiqui, A., Straus, S. E., Fahim, C.
10.1101/2025.01.23.25320556 — Posted: 2025-01-25
Uncertainty and Inconsistency of COVID-19 Non-Pharmaceutical Intervention Effects with Multiple Competitive Statistical Models
Mueller, B., Padberg, I., Lorke, M., Brinks, R., Cripps, S., Gomes, M. G. M., Haake, D., Ioannidis, J. P. A.
10.1101/2025.01.22.25320783 — Posted: 2025-01-25
Identification of a novel false-positive mechanism in RapidFire mass spectrometry and application in drug discovery
Pearson, L.-A., Lin, D., Ahmad, S. A., O'Neill, S., Post, J. M., Robinson, C., Scott, D. E., Gilbert, I. H.
10.1101/2025.01.24.634670 — Posted: 2025-01-24
A single dimer of the SARS-CoV-2 N protein can associate with multiple fragments of single-stranded and stem-loop RNAs
Kaneda, N., Suzuki, L., Endo, S., Husna, S. M. A., Ishikawa, S., Takahashi, H., Oikawa, H., Itoh, Y., Takahashi, S.
10.1101/2025.01.23.634602 — Posted: 2025-01-24
Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies
Haddox, H. K., Abdel Aziz, O., Galloway, J. G., Kent, J., Cooper, C. R., Bloom, J. D., Matsen, F. A.
10.1101/2025.01.22.634135 — Posted: 2025-01-24
Evidence of Resiliency in Maternal Health Services and Outcomes in Kono District, Sierra Leone during the COVID-19 Pandemic: An Observational Study
Boima, F., Mekonnen, Z. A., Koroma, M. M., Lado, M., Chan, A. K., Mishra, S., Njai, A. U., Molleh, B., Sevalie, S., Lakoh, S.
10.1101/2025.01.22.25320951 — Posted: 2025-01-24
A trans-amplifying mRNA vaccine with consensus spike elicits broadly cross-neutralizing antibody response against multiple SARS-CoV-2 variants
Gontu, A., Misra, S., Chothe, S. K., Ramasamy, S., Jakka, P., Byukusenge, M., LaBella, L. C., Nair, M. S., Jayarao, B. M., Archetti, M., Nissly, R. H., Kuchipudi, S. V.
10.1101/2025.01.22.634352 — Posted: 2025-01-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).